Is National HealthCare Corporation (NHC) overvalued? · P/E 15, rev $1.31B
National HealthCare Corporation (NHC) is a medical care facilities company listed on US.
This page asks whether National HealthCare Corporation (NHC) looks expensive on cached numbers — not a short thesis.
Latest reported NHC revenue for 2024-12-31 was $1.31B. Net income was $102.1M. Revenue was up 14.5% from 2023-12-31 to 2024-12-31. NHC currently screens at market cap $1.60B and trailing P/E 14.9.
NHC currently screens at market cap $1.60B and trailing P/E 14.9. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next NHC 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the NHC stock page for the full model, not this heading.
Not investment advice.